104 related articles for article (PubMed ID: 24083683)
1. TGF-beta1 is associated with the progression of intracranial deep white matter lesions: a pilot study with 5 years of magnetic resonance imaging follow-up.
Kuriyama N; Mizuno T; Kita M; Yamada K; Ozaki E; Matsumoto S; Takada A; Watanabe A; Kasai T; Nagakane Y; Mitani S; Matsui D; Watanabe I; Takeda K; Nakagawa M; Watanabe Y
Neurol Res; 2014 Jan; 36(1):47-52. PubMed ID: 24083683
[TBL] [Abstract][Full Text] [Related]
2. Intracranial deep white matter lesions (DWLs) are associated with chronic kidney disease (CKD) and cognitive impairment: a 5-year follow-up magnetic resonance imaging (MRI) study.
Kuriyama N; Mizuno T; Ohshima Y; Yamada K; Ozaki E; Shigeta M; Mitani S; Kondo M; Matsumoto S; Takeda K; Nakagawa M; Watanabe Y
Arch Gerontol Geriatr; 2013; 56(1):55-60. PubMed ID: 22177547
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme and progression of white matter lesions and brain atrophy--the SMART-MR study.
Jochemsen HM; Geerlings MI; Grool AM; Vincken KL; Mali WP; van der Graaf Y; Muller M
J Alzheimers Dis; 2012; 29(1):39-49. PubMed ID: 22214784
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of transforming growth factor-beta 1 before and after removal of low- and high-grade astrocytomas.
Loh JK; Lieu AS; Su YF; Cheng CY; Tsai TH; Lin CL; Lee KS; Hwang SL; Kwan AL; Wang CJ; Hong YR; Chio CC; Howng SL
Cytokine; 2013 Feb; 61(2):413-8. PubMed ID: 23260996
[TBL] [Abstract][Full Text] [Related]
5. Cerebral white matter lesions in primary Sjögren's syndrome: a controlled study.
Coates T; Slavotinek JP; Rischmueller M; Schultz D; Anderson C; Dellamelva M; Sage MR; Gordon TP
J Rheumatol; 1999 Jun; 26(6):1301-5. PubMed ID: 10381047
[TBL] [Abstract][Full Text] [Related]
6. White matter hyperintensities and cognitive dysfunction in Alzheimer disease.
Heo JH; Lee ST; Kon Chu ; Park HJ; Shim JY; Kim M
J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):207-12. PubMed ID: 19433863
[TBL] [Abstract][Full Text] [Related]
7. Low vitamin and carotenoid levels are related to cerebral white matter lesions.
Ohshima Y; Mizuno T; Yamada K; Matsumoto S; Nagakane Y; Kondo M; Kuriyama N; Miyazaki T; Takeda K; Nishimura T; Nakagawa M; Ozasa K; Watanabe Y
J Nutr Health Aging; 2013; 17(5):456-60. PubMed ID: 23636547
[TBL] [Abstract][Full Text] [Related]
8. White matter lesions on magnetic resonance imaging and their relationship with vascular risk factors in memory clinic attenders.
Lazarus R; Prettyman R; Cherryman G
Int J Geriatr Psychiatry; 2005 Mar; 20(3):274-9. PubMed ID: 15717341
[TBL] [Abstract][Full Text] [Related]
9. Lacunar infarcts in deep white matter are associated with higher and more fluctuating depressive symptoms during three years follow-up.
Grool AM; Gerritsen L; Zuithoff NP; Mali WP; van der Graaf Y; Geerlings MI
Biol Psychiatry; 2013 Jan; 73(2):169-76. PubMed ID: 23079234
[TBL] [Abstract][Full Text] [Related]
10. White matter changes on magnetic resonance imaging: a risk factor for stroke in an African population?
Ogbole GI; Owolabi MO; Yusuf BP
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e227-33. PubMed ID: 23375720
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine and progression of generalized small-vessel disease: the SMART-MR Study.
Kloppenborg RP; Geerlings MI; Visseren FL; Mali WP; Vermeulen M; van der Graaf Y; Nederkoorn PJ;
Neurology; 2014 Mar; 82(9):777-83. PubMed ID: 24477110
[TBL] [Abstract][Full Text] [Related]
12. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
[TBL] [Abstract][Full Text] [Related]
13. Loss of white matter integrity is associated with gait disorders in cerebral small vessel disease.
de Laat KF; Tuladhar AM; van Norden AG; Norris DG; Zwiers MP; de Leeuw FE
Brain; 2011 Jan; 134(Pt 1):73-83. PubMed ID: 21156660
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
15. Association between α-Klotho and Deep White Matter Lesions in the Brain: A Pilot Case Control Study Using Brain MRI.
Kuriyama N; Ozaki E; Mizuno T; Ihara M; Mizuno S; Koyama T; Matsui D; Watanabe I; Akazawa K; Takeda K; Takada A; Inaba M; Yamada S; Motoyama K; Takeshita W; Iwai K; Hashiguchi K; Kobayashi D; Kondo M; Tamura A; Yamada K; Nakagawa M; Watanabe Y
J Alzheimers Dis; 2018; 61(1):145-155. PubMed ID: 29154273
[TBL] [Abstract][Full Text] [Related]
16. Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with CKD.
Martinez-Vea A; Salvadó E; Bardají A; Gutierrez C; Ramos A; García C; Compte T; Peralta C; Broch M; Pastor R; Angelet P; Marcas L; Saurí A; Oliver JA
Am J Kidney Dis; 2006 Feb; 47(2):241-50. PubMed ID: 16431253
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging of the brain in patients with pseudoexfoliation syndrome and glaucoma.
Yüksel N; Anik Y; Altintaş O; Onur I; Cağlar Y; Demirci A
Ophthalmologica; 2006; 220(2):125-30. PubMed ID: 16491036
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive liver fibrosis markers: use of serum levels of cytokines IL 1α and TGF ß1 in management of chronic liver diseases.
Mehmedović A; Mesihović R; Prnjavorac B; Vanis N; Vukobrat-Bijedić Z; Borovac N; Zubčević N; Pilav A; Gornjaković S; Kulo-Ćesić A; Mujarić E; Saray A
Med Glas (Zenica); 2013 Feb; 10(1):20-7. PubMed ID: 23348156
[TBL] [Abstract][Full Text] [Related]
19. Decreased serum transforming growth factor-β1 concentration with aging is associated with the severity of emphysema in chronic obstructive pulmonary disease.
Kamio K; Ishii T; Motegi T; Hattori K; Kusunoki Y; Azuma A; Gemma A; Kida K
Geriatr Gerontol Int; 2013 Oct; 13(4):1069-75. PubMed ID: 23441714
[TBL] [Abstract][Full Text] [Related]
20. Elevated Plasma Transforming Growth Factor β1 Levels Predict the Development of Hypertension in Normotensives: The 14-Year Follow-Up Study.
Nakao E; Adachi H; Enomoto M; Fukami A; Kumagai E; Nakamura S; Nohara Y; Kono S; Sakaue A; Morikawa N; Tsuru T; Fukumoto Y
Am J Hypertens; 2017 Aug; 30(8):808-814. PubMed ID: 28575138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
